EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Isolation, Characterization, and Unlocking the Potential of Mimir124 Phage for Personalized Treatment of Difficult, Multidrug-Resistant Uropathogenic E. coli Strain

Alla Golomidova, Yuriy Kupriyanov iD, Ruslan Gabdrakhmanov, Marina Gurkova, Eugene Kulikov iD, Ilya Belalov iD, Viktoria Uskevich, Dmitry Bespiatykh iD, Maria Letarova iD, Alexander Efimov, Alexander Kuznetsov iD, Egor Shitikov iD und 3 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252312755 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Alla Golomidova und 14 weiteren Autor:innen. Beteiligte Einrichtung: Winogradsky Institute of Microbiology, RC Biotechnology RAS, Prospekt 60-Letiya Oktyabrya 7 Bld. 2, 117312 Moscow, Russia. Hauptthemen laut MEDLINE: Uropathogenic Escherichia coli, Phage Therapy, Drug Resistance, Multiple, Bacterial, Escherichia coli Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Escherichia coli and its bacteriophages are among the most studied model microorganisms. Bacteriophages for various E. coli strains can typically be easily isolated from environmental sources, and many of these viruses can be harnessed to combat E. coli infections in humans and animals. However, some relatively rare E. coli strains pose significant challenges in finding suitable phages. The uropathogenic strain E. coli UPEC124, isolated from a patient suffering from neurogenic bladder dysfunction, was found to be resistant to all coliphages in our collections, and initial attempts to isolate new phages failed. Using an improved procedure for phage enrichment, we isolated the N4-related phage Mimir124, belonging to the Gamaleyavirus genus, which was able to lyse this “difficult” E. coli strain. Although Mimir124 is a narrow-spectrum phage, it was effective in the individualized treatment of the patient, leading to pathogen eradication. The primary receptor of Mimir124 was the O antigen of the O101 type; consequently, Mimir124-resistant clones were rough (having lost the O antigen). These clones, however, gained sensitivity to some phages that recognize outer membrane proteins as receptors. Despite the presence of nine potential antiviral systems in the genome of the UPEC124 strain, the difficulty in finding effective phages was largely due to the efficient, non-specific cell surface protection provided by the O antigen. These results highlight the importance of an individualized approach to phage therapy, where narrow host-range phages—typically avoided in pre-fabricated phage cocktails—may be instrumental. Furthermore, this study illustrates how integrating genomic, structural, and functional insights can guide the development of innovative therapeutic strategies, paving the way for broader applications of phage therapy in combating multidrug-resistant bacterial pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uropathogenic Escherichia coliPhage TherapyDrug Resistance, Multiple, BacterialEscherichia coli InfectionsHumansBacteriophagesPrecision MedicineGenome, ViralColiphagesUrinary Tract Infections

Stichwörter der Autor:innen

GamaleyavirusN4-like bacteriophageO101 O-antigenUPECantibacterial drug resistancebacteriophagepersonalized phage therapyphage defense systemstherapy-recalcitrant pathogens

Autor:innen und Institutionen

  • Winogradsky Institute of Microbiology, RC Biotechnology RAS, Prospekt 60-Letiya Oktyabrya 7 Bld. 2, 117312 Moscow, Russia.
  • Department of Urology, Russian University of Medicine (ROSUNIMED), 2nd Botkinsky Proezd, 5 Bldg 20, 125284 Moscow, Russia.
  • Research and Production Center "MicroMir", Nizhny Kiselny Lane 5/23 Bldg 1, 107031 Moscow, Russia.
  • Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Malaya Pirogovskaya ul. 1a, 119435 Moscow, Russia.

ORCID-Profile: Yuriy Kupriyanov, Eugene Kulikov, Ilya Belalov, Dmitry Bespiatykh, Maria Letarova, Alexander Kuznetsov, Egor Shitikov

Zitieren

APA

Golomidova, A., Kupriyanov, Y., Gabdrakhmanov, R., Gurkova, M., Kulikov, E., Belalov, I., Uskevich, V., Bespiatykh, D., Letarova, M., Efimov, A., Kuznetsov, A., Shitikov, E., Pushkar, D., Letarov, A., & Zurabov, F. (2024). Isolation, Characterization, and Unlocking the Potential of Mimir124 Phage for Personalized Treatment of Difficult, Multidrug-Resistant Uropathogenic E. coli Strain. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312755

Vancouver

Golomidova A, Kupriyanov Y, Gabdrakhmanov R, Gurkova M, Kulikov E, Belalov I, et al. Isolation, Characterization, and Unlocking the Potential of Mimir124 Phage for Personalized Treatment of Difficult, Multidrug-Resistant Uropathogenic E. coli Strain. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312755

BibTeX
@article{Golomidova2024,
  author = {Golomidova, Alla and Kupriyanov, Yuriy and Gabdrakhmanov, Ruslan and Gurkova, Marina and Kulikov, Eugene and Belalov, Ilya and Uskevich, Viktoria and Bespiatykh, Dmitry and Letarova, Maria and Efimov, Alexander and Kuznetsov, Alexander and Shitikov, Egor and Pushkar, Dmitry and Letarov, Andrey and Zurabov, Fedor},
  title = {Isolation, Characterization, and Unlocking the Potential of Mimir124 Phage for Personalized Treatment of Difficult, Multidrug-Resistant Uropathogenic E. coli Strain},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252312755}
}
Kostenlos starten →